Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal
Sources: Official press releases and filings investors.adverum.com investors.adverum.com, Reuters, Investing.com, Fierce Biotech fiercebiotech.com, and analyst reports marketbeat.com marketbeat.com. All data as of market close Oct. 23, 2025 and news through Oct. 24,